查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1864448

按技術、產品、應用、最終用戶和自動化程度分類的自動化微生物市場—2025-2032年全球預測

Automated Microbiology Market by Technology, Product, Application, End User, Automation Level - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，自動化微生物市場規模將達到 317.9 億美元，複合年成長率為 12.36%。

關鍵市場統計數據
基準年 2024 125.1億美元
預計年份：2025年 140.3億美元
預測年份 2032 317.9億美元
複合年成長率 (%) 12.36%

實驗室主任的自動化微生物學策略指南：確定技術整合、營運重點和實際實施路徑

自動化微生物學已從一種小眾的實驗室輔助工具發展成為擴充性、可靠的診斷和分析工作流程的核心基礎。光學成像、分子檢測、質譜和資訊科學的進步融合在一起，加快了結果獲取速度，減少了人為誤差，並在臨床診斷、食品安全、環境監測和生物製藥品管等領域開闢了新的應用情境。隨著實驗室面臨檢體量不斷增加、監管要求日益嚴格以及訓練有素的技術人員短缺等挑戰，對自動化的投資正在提高檢測通量和可重複性，並重塑實驗室的營運重點。

本執行摘要概述了當前行業格局，整合了對企業高管和實驗室負責人至關重要的技術趨勢、商業性動態和營運考慮。它重點闡述了諸如可將資料傳輸至下游數位分析的自動化菌落計數器以及可減少人工操作時間的整合定序工作流程等漸進式創新如何創造協同效應和新的價值提案。同樣重要的是系統級整合，即將儀器連接到實驗室資訊管理系統和數位儀表板，從而實現即時決策支援。本報告說明實際實施管治，包括試點設計、檢驗考慮和跨職能管理，以確保自動化解決方案在不影響核心品管的前提下，帶來可衡量的改進。

目標是為決策者提供清晰、可操作的視角，了解自動化微生物學能力目前處於什麼狀態，它們可能如何在營運環境中實施，以及哪些組織槓桿可以加快實施速度，同時保持合規性以及臨床和分析準確性。

分子檢測、質譜、智慧軟體和供應鏈設計等領域的進步如何融合，正在重新定義實驗室自動化策略

自動化微生物學領域正受到多項變革性變化的重塑，這些變化共同改變了實驗室評估價值和衡量績效的方式。其中一個關鍵促進因素是分子技術的進步，這些技術已超越概念驗證階段，發展成為實用且整合的工作流程。次世代定序和先進的PCR平台正日益被納入常規診斷和監測實踐中，它們作為傳統培養方法的補充而非替代。同時，質譜鑑定技術的改進和高通量流式細胞技術的進步，拓展了可快速、可重複分析的微生物種類和檢體類型。

同時，軟體和系統整合已成為關鍵的差異化因素。實驗室資訊管理系統 (LIMS) 和整合儀器套件實現了閉合迴路工作流程，其中檢體元資料、儀器輸出和品管記錄同步，從而加快了根本原因分析並提高了法規遵循的可追溯性。人工智慧和機器學習正擴大應用於基於影像的菌落計數和頻譜解釋，在改進自動決策規則的同時，減少了人工標註的需求。供應鏈的韌性和試劑的可用性促進了模組化自動化方法的實施，使實驗室能夠根據自身工作流程的成熟度，選擇性地擴展規模，最初使用半自動儀器，然後過渡到全自動平台。

監管和報銷途徑也在不斷演變，監管機構越來越重視自動化系統的可追溯性、方法檢驗和上市後監測。這些變化正在創造一種環境，在這種環境下，自動化決策受到臨床和分析需求、營運限制以及軟體和耗材夥伴關係生態系統方法的綜合驅動。

關稅累積變化導致的營運和採購調整正在影響籌資策略、總體擁有成本考量和應對措施。

貿易政策發展和關稅調整措施（將持續到2025年）正對測試設備、耗材和整合系統的採購和實施產生累積影響。進口零件和成品設備關稅上漲導致成本增加，促使採購部門重新評估供應商組合，強調簽訂長期合約以降低價格波動風險，並考慮優先選擇區域製造地和擁有國內庫存的經銷商等替代籌資策略。這種轉變使得採購部門更加關注總體擁有成本而非僅僅關注採購價格，前置作業時間、服務能力和備件供應情況在採購決策中變得越來越重要。

為因應此局面，製造商和經銷商正採取多種措施，例如本地組裝、選擇性地對受關稅影響較小的組件進行設計變更，以及增加國內倉庫中關鍵試劑和任務關鍵型備件的儲備。實驗室在資本支出方面變得更加謹慎，傾向於採用可逐步升級的模組化系統。生命週期管理技術，例如多站點服務合約和耗材共用協議，正被用於分散財務風險並維持業務連續性。

事實上，關稅帶來的變化正在加速關於戰略韌性的討論，包括確保關鍵部件的多元化來源、投資於供應商中立介面以最大限度地減少對供應商的依賴，以及加強監管文件以加快替代供應商的資格認證。這些措施，加上採購和財務部門的先進情境規劃，正在幫助實驗室適應跨境貿易政策成為產業計畫關鍵因素的商業環境。

一種基於精細細分的觀點，將技術平台、產品類型、實驗室應用和自動化成熟度與實際應用模式連結起來。

詳細的細分分析揭示了不同技術、產品、應用、最終用戶和自動化程度下，採用模式和價值促進因素的差異。在技​​術方面，基於培養的方法仍然是表現型確認的核心，並透過自動化菌落計數器、自動化培養系統以及自動化染色和顯微鏡技術不斷最佳化，從而減少人工操作時間並提高可重複性。流式細胞技術可在環境和臨床應用中提供快速的細胞和顆粒分析，而質譜分析則能夠可靠地鑑定複雜樣本。諸如微陣列、次世代定序和PCR/即時PCR分子生物學方法正在拓展診斷範圍，實現先前難以大規模應用的基因組監測和多重檢測。

產品細分突出了耗材和試劑、儀器和軟體以及服務的不同商業性和營運考慮。整合系統、實驗室資訊管理系統和獨立儀器具有不同的實施規模和驗證要求，這會影響採購週期和服務模式。按應用細分，學術和研究機構優先考慮用於方法開發的靈活研究級平台；臨床診斷需要針對遺傳性疾病、感染疾病和腫瘤疾病的穩健且檢驗的工作流程；環境檢測和食品飲料行業優先考慮通量和法規可追溯性；而製藥和生物技術用戶則優先考慮合規性和批次級質量保證。

最終用戶涵蓋學術研究機構、醫院和診斷實驗室、食品飲料公司、製藥公司以及參考實驗室等。醫院和診斷實驗室通常進一步細分為診所、私立醫院和公立醫院，每種類型的醫院都有不同的預算限制、法規結構和吞吐量需求。最後，自動化程度（全自動或半自動）是一個關鍵選擇，取決於實驗室的規模、技術專長和可用資金。許多機構採用混合策略，先使用半自動模組，然後再過渡到全自動系統。

區域監管差異、基礎設施投資和經銷夥伴關係如何影響美洲、歐洲、中東和非洲以及亞太地區的採用路徑

區域趨勢將對美洲、歐洲、中東和非洲以及亞太地區自動化微生物技術的應用、監管路徑和商業策略產生重大影響。在美洲，需求受制於多元化的醫療基礎設施、集中的臨床卓越中心以及能夠支援大規模自動化部署的一體化醫院網路。北美採購團隊優先考慮與醫院資訊系統的互通性以及對當地監管要求的合規性，而拉丁美洲市場的特點是集中式參考實驗室與新興的分散式檢查需求並存，這正在影響產品組合和服務模式。

歐洲、中東和非洲地區（EMEA）的法規環境和市場環境各不相同，因此很難採用統一的市場策略。西歐市場率先採用整合檢測系統，並高度重視正式的方法檢驗和跨國品質協調。該地區法規結構迫使供應商對臨床證據和服務交付進行本地化。該地區的新興市場可能優先考慮成本效益高的半自動化解決方案，這些方案允許逐步擴展產能，並且符合公共衛生政策。

亞太地區以其快速的基礎設施投資、強大的製造業生態系統以及對基因組學和分子診斷日益成長的需求而聞名。其應用模式涵蓋了從實施全自動定序和質譜分析流程的先進都市區參考中心，到選擇緊湊型半自動化平台的分散式臨床機構。在所有地區，供應商與當地經銷商之間的策略夥伴關係，以及對本地技術支援和培訓的投入，都是持續應用和提升營運績效的關鍵推動因素。

在競爭與合作並存的動態中，產品效能、軟體整合、檢驗支援和服務模式將決定產品的長期市場接受度和供應商偏好。

自動化微生物學領域的競爭格局呈現出混合型結構，包括專業儀器製造商、整合式系統供應商、試劑和耗材供應商以及服務機構。市場領導透過儀器性能、軟體整合、驗證支援以及能夠最大限度減少停機時間並確保可追溯性的全球服務網路來脫穎而出。儀器原始設備製造商 (OEM) 與試劑合作夥伴之間的策略聯盟日益普遍，這種捆綁式服務簡化了採購和驗證流程，但也引發了人們對供應商鎖定和互通性的擔憂。

創新正在多個層面展開：硬體層面，更緊湊、模組化的儀器專為分散式環境而設計；檢測層面，多重分子檢測和穩健的樣品製備化學方法不斷湧現；軟體層面，分析功能、品管演算法以及與實驗室資訊管理系統 (LIMS) 的整合，都旨在提升營運價值。服務模式也在不斷演變，延長保固期、基於績效的服務協議以及雲端遠距離診斷已成為高通量實驗室的標準配備。擁有深厚專業知識和可擴展支援基礎設施的公司正成為參考實驗室和醫院網路的首選，而專注於獨特檢測能力和成本最佳化工作流程的創新企業則繼續開拓專業市場。

與學術機構建立合作關係並參與多中心檢驗研究對於商業性信譽至關重要，尤其對於那些影響臨床決策的技術而言更是如此。在競爭日益激烈的市場環境中，那些優先考慮開放架構、透明檢驗資料和終端使用者培訓的供應商將更有利於將試驗計畫轉化為長期應用。

為領導者提供實用且具戰術性的建議，這些建議結合了漸進式自動化、採購彈性、互通性、勞動力發展和夥伴關係策略。

行業領導者應採取一系列綜合措施，使技術選擇與營運韌性和監管準備保持一致。首先，應採取分階段的自動化策略，先進行試點部署，檢驗工作流程整合、方法可轉移性和員工培訓需求，然後再擴展到完整的自動化套件。這可以降低部署風險，並隨著偵測需求和供應鏈狀況的變化而保持靈活性。其次，在設計採購和合約方案時，應強調整體擁有成本、可預測的服務水準以及明確的備件和試劑供應承諾，以降低關稅和物流波動帶來的風險。

第三，從一開始就投資於軟體和數據互通性，以確保與實驗室資訊管理系統、電子健康記錄（如適用）以及用於效能監控的中央儀表板無縫整合。開放介面和標準化資料格式可降低長期整合成本，並支援多供應商環境。第四，優先考慮員工發展，並將培訓計劃、能力評估和交叉培訓納入實施計劃，以確保實驗室人員能夠管理自動化工作流程、解讀結果和維護設備。

最後，與檢驗合作夥伴、區域服務供應商和監管顧問建立策略聯盟，以加速市場准入並確保合規性。制定情境規劃，考慮貿易政策變化、試劑供應中斷和人員限制等因素，有助於經營團隊在速度、可靠性和可追溯性帶來競爭優勢的市場環境中，保持業務連續性並做出明智的資本配置決策。

採用嚴謹的混合調查方法，結合關鍵相關人員的訪談、同儕審查的技術證據以及有針對性的技術和商業性評估。

本執行摘要的研究結合了對實驗室主任、採購人員、臨床病理學家和高級研發科學家的定性訪談，以及對技術文獻、監管指導文件和產品技術資料的系統性回顧。主要訪談著重於實際應用中的挑戰，例如檢體處理量差異、人員能力和維護物流，旨在揭示操作挑戰、檢驗方法和採購行為。次要來源的選擇調查方法的嚴謹性，包括同行評審的研究、已發布的監管指南和供應商技術規範，以驗證有關性能和預期用途的說法。

我們的分析方法優先考慮對定性研究結果和已記錄的技術證據進行交叉檢驗，以確保建議基於可觀察的實踐而非供應商的說法。我們的技術評估著重考察了檢測性能特徵、週轉時間、整合要求和標準服務覆蓋範圍。我們的商業分析則著重於影響實施時間的採購因素、合約結​​構和分銷模式。在條件允許的情況下，我們納入了多中心檢驗研究和臨床性能評估的證據，以評估其在不同檢測環境下的穩健性。

本調查方法的限制包括不同司法管轄區報告細則的差異以及軟體功能的不斷演變（其變化速度可能快於硬體更新周期）。為彌補這些局限性，分析重點關注持續存在的營運和策略主題，並建議在進行大規模部署之前進行有針對性的試點研究，以檢驗在實際應用中的表現。

將戰略要務和營運實際情況結合，從而在臨床、工業和研究實驗室中成功實施自動化。

自動化微生物學正處於一個轉折點，技術成熟度、營運壓力和監管要求在此交匯，對實驗室決策者提出了新的要求。改進的分子檢測工作流程、先進的鑑定技術和更智慧的軟體生態系統正在共同推動臨床、工業和研究領域更可靠、擴充性的檢測。儘管不同應用、最終用戶和地理環境的採用路徑仍會有所不同，但互通性、供應鏈韌性、員工準備和檢驗等通用要素將始終是成功實施的關鍵。

經營團隊和檢驗負責人應將自動化視為組織轉型，而不僅僅是技術升級。這需要周密的變革管理、跨職能的管治以及循序漸進的風險緩解。在關稅和貿易政策使採購複雜化的情況下，應優先考慮採購和合約設計的靈活性，以確保營運的連續性。最終，能夠將自動化投資轉化為可衡量改進的檢驗機構，將是那些將謹慎的試點、嚴格的檢驗和持續的培訓與支持長期可維護性和合規性的戰略夥伴關係關係相結合的機構。

本文彙編的見解指南策略規劃，並提供切實可行的步驟，以加快實現自動化效益，同時保障品質和營運彈性。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 利用人工智慧和機器學習演算法進行快速微生物鑑定和抗菌藥物敏感性測試
  • 將機器人和自動化平台整合到臨床微生物實驗室中，以簡化樣本製備工作流程
  • 開發雲端基礎的數據分析解決方案，實現微生物檢測結果的即時監控和遠端存取。
  • 多重微流體系統的出現使得在單次檢測中同時檢測多種病原體成為可能。
  • 監管核准和標準化措施促進診斷實驗室採用自動化系統

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 自動化微生物市場：依技術分類

  • 文化基礎
    • 自動菌落計數器
    • 自動化培養系統
    • 自動化染色和顯微鏡
  • 流式細胞技術
  • 質譜分析
  • 分子鹼
    • 微陣列
    • 次世代定序
    • PCR/即時PCR

第9章 自動化微生物市場：依產品分類

  • 耗材和試劑
  • 設備和軟體
    • 整合系統
    • 實驗室資訊管理系統
    • 獨立設備
  • 服務

第10章 自動化微生物市場：依應用領域分類

  • 學術和研究領域
  • 臨床診斷
    • 遺傳性疾病
    • 感染疾病
    • 腫瘤學
  • 環境測試
  • 食品/飲料
  • 製藥和生物技術

第11章：按最終用戶分類的自動化微生物市場

  • 學術和研究機構
  • 食品和飲料製造商
  • 醫院和診斷實驗室
    • 診所
    • 私立醫院
    • 公立醫院
  • 製藥公司
  • 參考檢驗機構

12. 依自動化程度分類的自動化微生物市場

  • 全自動
  • 半自動

第13章：按地區分類的自動化微生物市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 按組別分類的自動化微生物市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國自動化微生物市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • bioMerieux SA
    • Becton, Dickinson and Company
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Siemens Healthineers AG
    • Merck KGaA
    • Sysmex Corporation
    • PerkinElmer, Inc.
    • bio-Rad Laboratories, Inc.
    • Abbott Laboratories
Product Code: MRR-F97DD5A7DBA7

The Automated Microbiology Market is projected to grow by USD 31.79 billion at a CAGR of 12.36% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 12.51 billion
Estimated Year [2025] USD 14.03 billion
Forecast Year [2032] USD 31.79 billion
CAGR (%) 12.36%

A strategic orientation to automated microbiology that clarifies technology convergence, operational priorities, and practical adoption pathways for laboratory leaders

Automated microbiology has evolved from a niche laboratory enhancement into a core enabler of scalable, reliable diagnostic and analytical workflows. Advances across optical imaging, molecular detection, mass spectrometry, and informatics have converged to shorten time-to-result, reduce human variability, and unlock new use cases in clinical diagnostics, food safety, environmental monitoring, and biopharmaceutical quality control. As laboratories contend with increasing sample volumes, tighter regulatory demands, and a shortage of trained technicians, automation investments deliver both throughput and reproducibility gains, reshaping operational priorities.

This executive summary frames the current landscape by synthesizing technology trajectories, commercial dynamics, and operational considerations that matter to C-suite and laboratory leaders. It identifies how incremental innovations-such as automated colony counters that feed downstream digital analysis, or integrated sequencing workflows that reduce hands-on time-are compounding to create new value propositions. Equally important are the system-level integrations that connect instruments to laboratory information management systems and digital dashboards, enabling real-time decision support. Throughout, emphasis is placed on practical adoption pathways: pilot designs, validation considerations, and cross-functional governance that ensure automated solutions deliver measurable improvements without disrupting core quality controls.

The objective is to equip decision-makers with a clear, actionable view of where automated microbiology capabilities are today, how they are likely to be deployed in operational settings, and which organizational levers accelerate adoption while maintaining compliance and clinical or analytical fidelity.

How converging advances in molecular assays, mass spectrometry, intelligent software, and supply chain design are redefining laboratory automation strategies

The automated microbiology landscape is being reshaped by several transformative shifts that collectively alter how laboratories assess value and measure performance. A primary driver is the maturation of molecular technologies that have moved beyond proof-of-concept to practical, integrated workflows; next-generation sequencing and advanced PCR platforms are increasingly embedded within routine diagnostic and surveillance pipelines, complementing classical culture-based methods rather than replacing them. At the same time, improvements in mass spectrometry identification and high-throughput flow cytometry have expanded the breadth of organisms and sample types that can be analyzed rapidly and reproducibly.

Concurrently, software and systems integration have become decisive differentiators. Laboratory information management systems and integrated instrument suites now enable closed-loop workflows where sample metadata, instrument outputs, and quality control records are synchronized, enabling faster root-cause analysis and regulatory traceability. Artificial intelligence and machine learning are making early inroads into image-based colony counting and spectral interpretation, improving automated decision rules while lowering the need for manual annotation. Supply chain resilience and reagent availability are stimulating modular automation approaches that let laboratories scale selectively, adopting semi-automated instruments initially before migrating to fully automated platforms as workflows mature.

Regulatory and reimbursement pathways are also evolving; agencies are placing greater emphasis on traceability, method validation, and post-market surveillance of automated systems. Together, these shifts are converging to create an environment where automation decisions are driven by a combination of clinical or analytical need, operational constraints, and an ecosystem approach to software and consumable partnerships.

Operational and procurement adjustments driven by cumulative tariff changes that are shaping sourcing strategies, total cost of ownership thinking, and resilience measures

Trade policy developments and tariff adjustments enacted through 2025 have had a cumulative effect on the procurement and deployment of laboratory instruments, consumables, and integrated systems. Tariff-induced cost increases for imported components and finished instruments have prompted procurement teams to reassess supplier portfolios, emphasize long-term contracts to mitigate price volatility, and consider alternative sourcing strategies that prioritize regional manufacturing or distributors with established domestic inventories. This shift has also heightened attention to total cost of ownership rather than headline purchase price, as lead times, servicing arrangements, and spare parts availability factor more prominently into procurement decisions.

Manufacturers and distributors have responded with a range of adaptations, including localized assembly, selective redesign to reduce tariff-sensitive content, and increased stocking of critical reagents and mission-critical spare parts within domestic warehouses. For laboratories, the net effect is a more cautious approach to capital expenditures and a preference for modular systems that can be upgraded incrementally. Lifecycle management practices, such as multi-site service agreements and shared consumable contracts, are being used to spread financial risk and maintain continuity of operations.

In practice, tariff-driven changes have accelerated conversations around strategic resilience: dual-sourcing critical components, investing in vendor-agnostic interfaces to minimize lock-in, and enhancing regulatory documentation to facilitate faster qualification of alternate suppliers. These measures, combined with more sophisticated scenario planning by procurement and finance teams, are helping laboratories adapt to a commercial environment in which cross-border trade policy is a material factor in operational planning.

A nuanced segmentation-driven perspective that connects technology platforms, product types, laboratory applications, and automation maturity to real-world adoption patterns

Deep segmentation analysis reveals differentiated adoption patterns and value drivers across technology, product, application, end user, and automation level axes. On the technology front, culture-based approaches remain central for phenotypic confirmation and are increasingly optimized through automated colony counters, automated culture systems, and automated staining and microscopy that reduce hands-on time and improve reproducibility. Flow cytometry provides rapid cellular and particulate analysis for environmental and clinical applications, while mass spectrometry offers high-confidence identification for complex samples. Molecular-based modalities such as microarray, next-generation sequencing, and PCR/real-time PCR are expanding diagnostic reach, enabling genomic surveillance and multiplexed detection that were previously impractical at scale.

Product segmentation highlights distinct commercial and operational considerations for consumables and reagents, instruments and software, and services. Integrated systems, laboratory information management systems, and standalone instruments present different implementation footprints and validation requirements, influencing procurement cycles and service models. Application-based segmentation shows that academic and research settings prioritize flexible, research-grade platforms for method development; clinical diagnostics demand robust, validated workflows for genetic disorders, infectious diseases, and oncology; environmental testing and food and beverage sectors emphasize throughput and regulatory traceability; while pharmaceutical and biotechnology users prioritize compliance and batch-level assurance.

End users range from academic and research institutions to hospitals and diagnostic laboratories, food and beverage companies, pharmaceutical firms, and reference laboratories. Hospitals and diagnostic labs often subdivide into clinics, private hospitals, and public hospitals, each with distinct budgetary constraints, regulatory frameworks, and throughput needs. Finally, automation level-whether fully automated or semi-automated-remains a decisive choice driven by laboratory scale, technical expertise, and capital availability, with many organizations adopting hybrid strategies that combine semi-automated modules during transition phases before committing to fully automated suites.

How regional regulatory diversity, infrastructure investment, and distribution partnerships shape distinct adoption pathways across the Americas, Europe Middle East and Africa, and Asia-Pacific

Regional dynamics materially influence technology adoption, regulatory pathways, and commercial strategies in automated microbiology across the Americas, Europe Middle East and Africa, and Asia-Pacific. In the Americas, demand is often shaped by healthcare infrastructure heterogeneity, concentrated centers of clinical excellence, and integrated hospital networks that can support larger-scale automation rollouts. North American procurement teams emphasize interoperability with hospital information systems and compliance with regional regulatory expectations, while Latin American markets are characterized by a mix of centralized reference labs and emerging decentralized testing needs, which affect product configuration and service models.

Europe, the Middle East and Africa present a diverse regulatory and market environment where single-market strategies rarely apply uniformly. Western European markets often lead in early adoption of integrated laboratory systems and place a high value on formal method validation and cross-border quality harmonization. Regulatory frameworks in the region require careful navigation, prompting vendors to localize clinical evidence and service offerings. Emerging markets within the region may prioritize cost-effective semi-automated solutions that enable incremental capacity expansion and align with public health initiatives.

Asia-Pacific stands out for rapid infrastructure investment, strong manufacturing ecosystems, and an accelerating appetite for genomics and molecular diagnostics. Adoption patterns range from highly advanced urban reference centers that deploy fully automated sequencing and mass spectrometry workflows to decentralized clinical settings that opt for compact, semi-automated platforms. Across all regions, strategic partnerships between vendors and regional distributors, as well as investments in local technical support and training, are critical enablers of sustained adoption and operational performance.

Competitive and collaborative dynamics where product performance, software integration, validation support, and service models determine long-term adoption and vendor preference

Competitive dynamics in automated microbiology are defined by a mix of specialized instrument manufacturers, integrated systems providers, reagent and consumable suppliers, and service organizations. Market leaders differentiate through a combination of instrument performance, software integration, validation support, and global service networks that minimize downtime and ensure traceability. Strategic alliances between instrument OEMs and reagent partners are increasingly common, creating bundled offerings that simplify procurement and validation but also raise questions about vendor lock-in and interoperability.

Innovation is occurring at multiple layers: at the hardware level with more compact, modular instruments designed for decentralized settings; at the assay level with multiplexed molecular tests and robust sample preparation chemistries; and at the software level where analytics, quality control algorithms, and LIMS integration drive operational value. Service models are likewise evolving, with extended warranties, outcome-based service agreements, and cloud-enabled remote diagnostics becoming standard expectations for high-throughput laboratories. Companies that combine deep domain expertise with scalable support infrastructures gain preference among reference labs and hospital networks, while niche innovators continue to capture specialist segments by focusing on unique assay capabilities or cost-optimized workflows.

Partnerships with academic centers and participation in multi-site validation studies also underpin commercial credibility, particularly for technologies that intersect with clinical decision-making. As competition intensifies, vendors that prioritize open architectures, transparent validation data, and end-user training will be better positioned to convert pilot programs into long-term deployments.

Practical and tactical recommendations for leaders that combine phased automation, procurement resilience, interoperability, workforce development, and partnership strategies

Industry leaders must pursue an integrated set of actions that align technology selection with operational resilience and regulatory readiness. First, adopt a phased automation strategy that begins with pilot deployments to validate workflow integration, method transferability, and staff training requirements before scaling to fully automated suites. This reduces implementation risk and preserves flexibility to pivot as assay needs or supply chain conditions change. Second, design procurement and contracting approaches that emphasize total cost of ownership, predictable service levels, and clear spare parts and reagent supply commitments to mitigate tariff and logistics volatility.

Third, invest in software and data interoperability from the outset to enable seamless integration with laboratory information management systems, electronic health records where applicable, and centralized dashboards for performance monitoring. Open interfaces and standardized data formats reduce long-term integration costs and support multi-vendor environments. Fourth, prioritize workforce development by embedding training programs, competency assessments, and cross-training within implementation plans to ensure laboratory personnel can manage automated workflows, interpret results, and maintain instruments.

Finally, cultivate strategic partnerships with validation partners, regional service providers, and regulatory advisors to accelerate market entry and sustain compliance. Scenario planning that accounts for trade policy shifts, reagent supply interruptions, and staffing constraints will help executives maintain continuity and make informed capital allocation decisions in a landscape where speed, reliability, and traceability confer competitive advantage.

A rigorous mixed-methods research approach combining primary stakeholder interviews, peer-reviewed technical evidence, and targeted technology and commercial assessments

The research underpinning this executive summary combined primary qualitative engagements with laboratory directors, procurement leaders, clinical pathologists, and senior R&D scientists alongside a systematic review of technical literature, regulatory guidance documents, and product technical dossiers. Primary interviews were conducted to surface operational pain points, validation practices, and purchasing behaviors, with emphasis on real-world implementation challenges such as sample throughput variability, staff competency, and maintenance logistics. Secondary sources were selected for methodological rigor and included peer-reviewed studies, open regulatory guidance, and vendor technical specifications to triangulate claims about performance and intended use.

Analytical methods prioritized cross-validation between qualitative insights and documented technical evidence to ensure recommendations are grounded in observable practice rather than vendor positioning. Technology assessments evaluated assay performance characteristics, hands-on time, integration requirements, and typical service footprints. Commercial analysis focused on procurement drivers, contractual structures, and distribution models that affect time-to-deployment. Where possible, evidence from multi-site validation studies and clinical performance evaluations was incorporated to evaluate robustness across diverse laboratory settings.

Limitations of the methodology include variability in reporting granularity across jurisdictions and the evolving nature of software-enabled features, which may shift more rapidly than hardware cycles. To mitigate these limitations, the analysis emphasizes durable operational and strategic themes and recommends targeted pilot studies to validate context-specific performance prior to large-scale rollouts.

Synthesis of strategic imperatives and operational realities that define successful automation deployments in clinical, industrial, and research laboratories

Automated microbiology is at an inflection point where technological maturity, operational pressures, and regulatory demands intersect to create new imperatives for laboratory decision-makers. The combination of improved molecular workflows, advanced identification technologies, and smarter software ecosystems is enabling more reliable and scalable testing across clinical, industrial, and research contexts. Adoption pathways will continue to vary by application, end user, and regional context, but common themes-interoperability, supply chain resilience, workforce readiness, and validated performance-consistently determine successful deployments.

Executives and laboratory leaders should view automation as both a technical upgrade and an organizational transformation that requires deliberate change management, cross-functional governance, and incremental risk mitigation. Where tariffs and trade policy considerations introduce procurement complexity, leaders should prioritize flexibility in sourcing and contractual design to preserve operational continuity. Ultimately, the laboratories that translate automation investments into measurable improvements will be those that combine thoughtful pilots, rigorous validation, and ongoing training with strategic partnerships that support long-term serviceability and compliance.

The insights summarized here are intended to guide strategic planning and to highlight practical levers that accelerate the realization of automation benefits while protecting quality and operational resilience.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of AI and machine learning algorithms for rapid microbial identification and antimicrobial susceptibility testing
  • 5.2. Integration of robotics and automation platforms to streamline sample preparation workflows in clinical microbiology labs
  • 5.3. Development of cloud-based data analytics solutions for real-time monitoring and remote access to microbial testing results
  • 5.4. Emergence of multiplexed microfluidic systems enabling simultaneous detection of multiple pathogens in single assays
  • 5.5. Regulatory approvals and standardization efforts driving implementation of automated systems in diagnostic laboratories

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Automated Microbiology Market, by Technology

  • 8.1. Culture Based
    • 8.1.1. Automated Colony Counters
    • 8.1.2. Automated Culture Systems
    • 8.1.3. Automated Staining & Microscopy
  • 8.2. Flow Cytometry
  • 8.3. Mass Spectrometry
  • 8.4. Molecular Based
    • 8.4.1. Microarray
    • 8.4.2. Next-Gen Sequencing
    • 8.4.3. Pcr/Real-Time Pcr

9. Automated Microbiology Market, by Product

  • 9.1. Consumables & Reagents
  • 9.2. Instruments & Software
    • 9.2.1. Integrated Systems
    • 9.2.2. Laboratory Information Management Systems
    • 9.2.3. Standalone Instruments
  • 9.3. Services

10. Automated Microbiology Market, by Application

  • 10.1. Academic & Research
  • 10.2. Clinical Diagnostics
    • 10.2.1. Genetic Disorders
    • 10.2.2. Infectious Diseases
    • 10.2.3. Oncology
  • 10.3. Environmental Testing
  • 10.4. Food & Beverage
  • 10.5. Pharmaceutical & Biotechnology

11. Automated Microbiology Market, by End User

  • 11.1. Academic & Research Institutions
  • 11.2. Food & Beverage Companies
  • 11.3. Hospitals & Diagnostic Laboratories
    • 11.3.1. Clinics
    • 11.3.2. Private Hospitals
    • 11.3.3. Public Hospitals
  • 11.4. Pharmaceutical Companies
  • 11.5. Reference Laboratories

12. Automated Microbiology Market, by Automation Level

  • 12.1. Fully Automated
  • 12.2. Semi-Automated

13. Automated Microbiology Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Automated Microbiology Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Automated Microbiology Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. bioMerieux SA
    • 16.3.2. Becton, Dickinson and Company
    • 16.3.3. Thermo Fisher Scientific Inc.
    • 16.3.4. Danaher Corporation
    • 16.3.5. Siemens Healthineers AG
    • 16.3.6. Merck KGaA
    • 16.3.7. Sysmex Corporation
    • 16.3.8. PerkinElmer, Inc.
    • 16.3.9. bio-Rad Laboratories, Inc.
    • 16.3.10. Abbott Laboratories

LIST OF FIGURES

  • FIGURE 1. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. AUTOMATED MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. AUTOMATED MICROBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. AUTOMATED MICROBIOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED COLONY COUNTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED COLONY COUNTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED COLONY COUNTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED COLONY COUNTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED COLONY COUNTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED COLONY COUNTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED STAINING & MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED STAINING & MICROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED STAINING & MICROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED STAINING & MICROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED STAINING & MICROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED STAINING & MICROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MICROARRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MICROARRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MICROARRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MICROARRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MICROARRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY NEXT-GEN SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY NEXT-GEN SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY NEXT-GEN SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY NEXT-GEN SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY NEXT-GEN SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY NEXT-GEN SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PCR/REAL-TIME PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PCR/REAL-TIME PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PCR/REAL-TIME PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PCR/REAL-TIME PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PCR/REAL-TIME PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PCR/REAL-TIME PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CONSUMABLES & REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CONSUMABLES & REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CONSUMABLES & REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CONSUMABLES & REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CONSUMABLES & REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CONSUMABLES & REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY STANDALONE INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY STANDALONE INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY STANDALONE INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY STANDALONE INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY STANDALONE INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY STANDALONE INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY GENETIC DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY GENETIC DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY GENETIC DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY GENETIC DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FULLY AUTOMATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FULLY AUTOMATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FULLY AUTOMATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FULLY AUTOMATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SEMI-AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SEMI-AUTOMATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SEMI-AUTOMATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SEMI-AUTOMATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SEMI-AUTOMATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SEMI-AUTOMATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 291. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 294. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 295. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 296. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA AUTOMATED MICROB